Kevin Fitzmaurice

Kevin Fitzmaurice has over 25 years of experience in the pharmaceutical industry. Kevin began their career in 1995 as an Associate Director of Production Technology at Boehringer Ingelheim Pharmaceuticals. In 1996, they moved to Penwest Pharmaceuticals, where they held the roles of Manager, Technical Operations, Associate Director, Technical Operations, and Director, Technical Operations. In 2011, they began working for KMF Consulting LLC as President, specializing in the manufacture, scale-up, technology transfer and validation of pharmaceutical dosage forms. Kevin also worked as a Contractor for Technical Operations/Specialty Generics at Endo Pharmaceuticals. From 2013 to 2019, they were employed at Acorda Therapeutics, Inc., where they held the roles of Assistant Director, Technical Operations and Director of Technical Operations. In 2019, they were appointed Senior Director of Technical Operations at Trevi Therapeutics, Inc.

Kevin Fitzmaurice obtained their BS in Biology from Saint Michael's College and their MS in Industrial Pharmacy from Long Island University between 1985 and 1989.